News

Over the past three months, elegslab has successfully completed the 2023 IRIS STARTUP CHALLENGE, an accelerating program hosted by SNU SLab and supported by the Seoul Business Agency (SBA). In recognition of its outstanding performance and growth potential, elegslab was honored with the Excellence Prize at the program's Demo Day. As Korea's first specialized CRO & CDMO focused on C. elegans-based alternative animal testing, elegslab showcased its integrated capabilities in in vivo screening, preclinical trials, and direct nano-formulation of hit and lead compounds. During the Demo Day, elegslab presented its innovative business model and scalable technology to a panel of judges composed of leading venture capital investment professionals, earning high marks for its vision to bridge the gap between discovery and clinical entry.